Clinical observation in treating acute isechemic stroke with butylphthalide soft capsules
HU Qiao-xia
Abstract
HU Qiao-xia
Abstract
OBJECTIVE To evaluate the effect of butylphthalide on treating acute ischemic stroke. METHODS The 63 patients with acute ischemic stroke treated by butylphthalide and 63 patients as randomized control group. RESULTS After treatment,the total efficacy rates in the treatment and control groups were 93.7% vs 79.4%,with significant difference in clinical efficacy between the two groups (P0.01). CONCLUSION Butylphthalide is safe and effective in treating acute isechemic stroke.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To evaluate the effect of butylphthalide on treating acute ischemic stroke. METHODS The 63 patients with acute ischemic stroke treated by butylphthalide and 63 patients as randomized control group. RESULTS After treatment,the total efficacy rates in the treatment and control groups were 93.7% vs 79.4%,with significant difference in clinical efficacy between the two groups (P0.01). CONCLUSION Butylphthalide is safe and effective in treating acute isechemic stroke.
Key concepts: Medicine, Clinical efficacy, Acute stroke, Stroke (engine), Treatment and control groups, Ischemic stroke, Significant difference, Randomized controlled trial